Detrol LA
Detrol LA is an extended-release antimuscarinic (anticholinergic) medication. It works by relaxing the detrusor muscle of the bladder, which helps reduce sudden bladder muscle contractions and decreases the sensation of urgency and the frequency of urination.
Dosage by Body Weight
The recommended starting dose for adults is 4 mg taken orally once daily with liquid. The dose may be reduced to 2 mg daily based on individual response and tolerability. For patients with severe renal or hepatic impairment, the recommended dose is 2 mg daily. Capsules must be swallowed whole and should not be chewed, crushed, or divided. Not recommended for pediatric use.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients have not been established. |
| 5-7 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients have not been established. |
| 8-10 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients have not been established. |
| 11-15 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients have not been established. |
| 16-20 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients have not been established. |
Formulation
Purpose
Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.
Generic Name
Tolterodine tartrateScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.